| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Risk Assessment
Record information and status
Record ID
111650
Status
Published
Date of creation
2017-02-07 08:12 UTC (german_bch@bvl.bund.de)
Date of last update
2017-04-12 14:07 UTC (german_bch@bvl.bund.de)
Date of publication
2017-05-30 14:13 UTC (222@bmel.bund.de)

This document is also available in the following languages:
General Information
Country
  • Germany
Title of risk assessment
6786-01-0103 (adv. 42010-0103) Summary of the risk assessment of a deliberate release (field trial) of genetically modified potato (Solanum tuberosum L.) 35S-alphaUMPS 21, 26, 29 and 73; B33-alphaUMPS 5, 8, 73 and 76; 35S-alphaAdK 4, 8, 20,24 and 28; 35S-PL 24, 28, 48 and 52; 35S-StPT2 26, 27 and 45; 35S-SAT 26 and 48, issued by the German Competent Authority
Date of the risk assessment
1999-05-11
Competent National Authority(ies) responsible for the risk assessment
Federal Office of Consumer Protection and Food Safety
Mauerstrasse 39-42
Berlin
Germany, 10117
Phone:+49-(0)3018-445-6500
Fax:+49-(0)3018-445-6099
Email:german_bch@bvl.bund.de
Url:http://www.biosafety-bch.de (english language),BVL Homepage (English)
Risk assessment details
Living modified organism
Potato modified for increased tuber weight
Changes in physiology and/or production - Yield Resistance to antibiotics - Kanamycin
Potato modified for increased tuber weight
Changes in physiology and/or production - Yield Resistance to antibiotics - Kanamycin
Potato modified for increased specific density
Changes in physiology and/or production - Yield Resistance to antibiotics - Kanamycin
Potato modified for an enhanced phosphate content in leaves, roots and tubers
Changes in physiology and/or production Changes in quality and/or metabolite content Resistance to antibiotics - Kanamycin
Potato modified for reduced cell wall stability
Changes in physiology and/or production Resistance to antibiotics - Hygromycin Selectable marker genes and reporter genes
Potato modified for tolerance to oxidative stress and heavy metals
Changes in quality and/or metabolite content - Antioxidants Resistance to antibiotics - Hygromycin Selectable marker genes and reporter genes Tolerance to abiotic stress
Scope of the risk assessment
Methodology and points to consider
Potential adverse effects identified in the risk assessment
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
Estimation of the overall risk
Adverse effects on human or animal health or on the environment are not expected.
Receiving environment(s) considered
1 field site in Germany
LMO detection and identification methods proposed
construct specific PCR-based method
Additional Information
Additional Information
-   deliberate release, no placing on the market.
-   field trial, not for human consumption or for feed purposes

-  There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/99/103

Records referencing this document (1)
IDDescription
1record(s) found
Country's Decision or any other Communication1 record